107. 若年性特発性関節炎 Juvenile idiopathic arthritis Clinical trials / Disease details

臨床試験数 : 441 / 薬物数 : 282 - (DrugBank : 56) / 標的遺伝子数 : 52 - 標的パスウェイ数 : 142

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00534495 (ClinicalTrials.gov)	November 2008	24/9/2007	Safety and Effectiveness of Rilonaceptfor Treating Systemic Juvenile Idiopathic Arthritis in Childre ...	Randomized Placebo Phase Study of Rilonaceptin the Treatment of Systemic Juvenile Idiopathic Arthrit ...	Juvenile Idiopathic Arthritis	Biological: Rilonacept	Montefiore Medical Center	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)	Completed	18 Months	19 Years	All	71	Phase 2	United States
2	NCT01803321 (ClinicalTrials.gov)	November 2005	28/2/2013	Study to Evaluate the Safety and Tolerability of Two Doses of Rilonaceptin Pediatric Subjects With A ...	A Pilot, Multi-center, Randomized, Double-Blind, Placebo-Controlled, Ascending Dose, Safety, Tolerab ...	Systemic Juvenile Idiopathic Arthritis	Drug: rilonacept (IL-1 Trap);Other: Placebo	Regeneron Pharmaceuticals	NULL	Completed	4 Years	20 Years	Both	24	Phase 1	United States

First Previous1Next Last